Mode
Text Size
Log in / Sign up

Adriamycin

1 published article · Updated continuously

Clinical Trial Landscape

Clinical Trials of Adriamycin

8 trials tracked of Adriamycin: 2 in phase 3 or 4 and 1 with published results. The most-cited published study has 14 citations.

8Trials tracked
2Phase 3 & 4
0Recruiting
1With published results
Phase distribution
Phase 3 2 Phase 2 5 Other / NA 1
  1. Phase 3 Comparison of Two Combination Chemotherapy Regimens in Treating Women With Breast Cancer Completed · 14 cited
  2. Phase 3 DTPACE Followed by Tandem Transplant With Melphalan (MEL) 200 Versus MEL/Dexamethasone/Thalidomide (DT) Platinol/Adriamycin/Etoposide (PACE) Hybrid and DTPACE Consolidation Completed
  3. Phase 2 AMG 531 in Patients With Advanced Malignancy Receiving Treatment With Carboplatin Completed
  4. Phase 2 Brentuximab Vedotin Plus AD in Non-bulky Limited Stage Hodgkin Lymphoma Completed
  5. Phase 2 Study of a-Interferon With Adriamycin, Bleomycin, Velban, and Dacarbazine (ABVD) With Hodgkin's Disease Completed
  6. Phase 2 Chemotherapy With Low-Dose Radiation for Pediatric Hodgkin Lymphoma Completed
Show 2 more trials
  1. Phase 2 Rituximab and ABVD for Hodgkin's Patients Completed
  2. N/A Palonosetron in Sarcoma Patients Receiving Chemotherapy With Adriamycin and Ifosfamide (AI) Completed

Showing the 8 most-cited and recently-updated of 8 trials. Browse the full registry →

Trial data sourced from ClinicalTrials.gov. Counts describe the research landscape and are not a treatment recommendation. Informational only — not medical advice.

HCP Mode — summaries include clinical detail, trial data, and statistical outcomes.
Patient Mode — summaries use plain language, avoiding clinical jargon.